What changes for a Shopify store once a cosmetic legally becomes an OTC drug?

Published September 4, 2026·Last verified September 4, 2026·
At a glance
Short answer
In the US: a monograph or approval route, a Drug Facts label and drug listing; registration falls on whoever makes, repacks, relabels or salvages it.
Where this page stops
Scope: US federal rules only. EU cosmetic law and any single molecule are outside this page.
Monograph is not automatic
Meeting section 505G, monograph included, skips the application; FDA says anything not conforming to a monograph needs an NDA.
The exemption has one condition
It holds only while you never manufacture, repack, relabel or salvage the product yourself.
No small-business fee break
FDA's draft OMUFA guidance: waivers and reductions are not authorized by statute; the applicable fee does not vary by size.
No Shopify reclassification workflow
No Shopify page we read on September 2, 2026 describes a re-tagging, re-review or re-underwriting on this change.
The cheaper way back
If the claim rather than the formula moved the product across the line, changing the label wording is cheaper.

Two regulatory pathways exist for a nonprescription drug in the U.S. — the drug application process and the OTC Drug Review, better known as the monograph process. A monograph product may be marketed without an approved application under section 505 of the FD&C Act if it meets section 505G, the monograph included. That door is narrow: active ingredient, strength, indication and label wording all have to sit inside a monograph that already exists.

Anything outside one goes the other way — FDA says products conforming to a monograph may be marketed without pre-approval, while those that do not must undergo separate review and approval through the New Drug Application process. No FDA page we read on September 2, 2026 describes a faster route for a product arriving from the cosmetic side. This is US federal law; the EU regulates the same jar separately.

What does a Drug Facts label add to the package?

A cosmetic label has no equivalent of the Drug Facts panel. FDA's standardized OTC panel prints in a fixed order, and seven of its headings are mandatory:

  • Active Ingredient(s)
  • Purpose(s)
  • Use(s)
  • Warning(s)
  • Directions
  • Other Information
  • Inactive Ingredients

Only “Questions?” or “Questions or comments?” is optional under 21 CFR 201.66(c); the rest of the panel is not yours to design.

The usual outcome is not that the jar stops being a cosmetic. A product that is legally both carries combination labeling: drug ingredients listed alphabetically as “Active Ingredients”, followed by the cosmetic ingredients in descending order of predominance as “Inactive Ingredients”. Both lists live on the same package.

Does facility registration reach you or your manufacturer?

Section 510 of the FD&C Act, codified in 21 CFR Part 207, puts registration on the maker. Drug manufacturers must register their establishments and list all drugs they manufacture for U.S. commercial distribution. If a contract manufacturer builds your formula and it ships under your brand name, FDA calls your side a private label distributor: a person who did not manufacture, repack, relabel, or salvage the drug but under whose label or trade name it is commercially distributed.

A PLD that does not engage in the manufacture, repacking, relabeling, or salvaging of a drug is exempt from registering with FDA, 21 CFR 207.17(b).
U.S. Food and Drug Administration — Drug Amount Reporting: Registration and Listing Regulatory Background, CDER, September 2022, slide 12 ·

Who owes what once the product is a drug

ObligationContract manufacturerYou, the brand owner
Facility registration (21 CFR Part 207)Registers its establishment under §207.17(a) and lists each drug under §207.41Exempt under §207.17(b) unless you make, repack, relabel or salvage
Drug listing (SPL)Files it unless you do, and names you as labelerMay file it yourself as the registrant's authorized agent; exactly one side files
NDC labeler codeLists the drug under its own code tooNeeds its own code either way
OMUFA facility feePays it if it owns an OTC monograph drug facility; CMO facilities includedNot a facility owner, not the payer

21 CFR Part 207 on ecfr.gov and the OMUFA facility fee page on fda.gov, read September 2–3, 2026.

Listing is the half you can choose. If the private label distributor provides the SPL file, the registrant does not submit one for that product; if it does not, the registrant files and names the distributor as the labeler. Either way you need your own NDC labeler code.

The OMUFA facility fee is assessed on qualifying persons who own an OTC monograph drug facility, and FDA's draft guidance on assessing those fees states that waivers and reductions are not authorized under the statute, so the same applicable facility fee — the monograph drug facility fee or the contract manufacturing organization fee — applies regardless of company size.

What changes inside your Shopify store?

Shopify does not have one rulebook here; it has two. Managed Markets classifies catalog items by destination country, and it keeps “Beauty and cosmetics” apart from “Ingestibles, wellness, and medical devices”, the category that carries OTC medicines. If the product moves between those lists, the restrictions it meets abroad move with it.

Shopify Payments eligibility is the second lane, and it names “Pseudo pharmaceuticals” — products making health claims not verified by a local or national regulatory body — separately from regulated products that need approval. The page says its own list is not exhaustive and varies by region.

What neither lane describes is the moment of the switch: no Shopify page we read on September 2, 2026 documents a re-tagging, a re-review or a re-underwriting triggered by a product changing regulatory class. Our page on peptide sales traces how a drug-adjacent product is treated in practice.

What we looked for and did not find
Read on September 2, 2026: FDA's nonprescription drug pathways, monograph, Drug Facts, registration-and-listing and OMUFA pages; Shopify's Managed Markets prohibited items and overview, Shopify Payments eligibility, the Acceptable Use Policy and the Payments terms.

The words on the label are the cheaper thing to change when a claim rather than the formula moved the product across the line — the test for that wording sits in our beauty-store guide.


About This Article

This article was written entirely by AI under human editorial direction. The editor sets the topic and structure, runs multi-stage validation on facts, links, and interactive elements, and verifies the output is useful from a business perspective. All claims are checked against official Shopify sources. Details may change — always confirm critical data at shopify.com.

Editorial Policy

Related questions

Stay updated

Get notified about new articles

Subscribe to receive updates when we publish new Shopify guides and insights.